Vical's Herpes Vaccine: New Lab Results Confirm Move To The Clinic
By Theodore Cohen: In August 2011 and February 2012 I pre sented detailed overviews of Vical
Incorporated's ( VICL
) herpes simplex virus type 2 or HSV-2 vaccine . Of the two serotypes identified, HSV-1 and HSV-2, the former is more common in the United States, but the latter is considered more ...
Read the rest of this article on Long Investing Ideas from Seeking Alpha